Ergoteles’s ImageneBio Inc IMA Stock Holding History

Ergoteles’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,467	Closed	-$46.8K	–	1478
2022 Q4	$46.8K	Sell	1,467 -6,920	-83%	-$221K	﹤0.01%	1300
2022 Q3	$357K	Sell	8,387 -1,283	-13%	-$74.2K	0.01%	895
2022 Q2	$514K	Buy	+9,670	New	+$533K	0.02%	824

Other funds holding IMA

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Ergoteles's IMA Position: Q1 2023 in Review

Ergoteles sold out of ImageneBio Inc (IMA) in Q1 2023, closing a stake of 1,467 shares — an estimated $46.8K sold.

Ergoteles first reported a position in IMA in Q2 2022 and held it in 3 quarters. The position peaked at $514K in Q2 2022. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2023.

Ergoteles reported no remaining ImageneBio Inc position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 1,467 ImageneBio Inc shares in Q1 2023, an estimated $46.8K.
Ergoteles first reported a position in ImageneBio Inc in Q2 2022 and held it in 3 quarters.
Ergoteles's ImageneBio Inc position peaked at $514K in Q2 2022.
39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.